Dennie Dyer

Transcept Pharmaceuticals, Inc. researches and develops biopharmaceutical products. The firm's products are used for pain, side effects of chemotherapy treatments, sleeplessness, and migraine headaches. Its drug delivery technology enhances absorption rates of active drug agents reduces absorption times. The company was founded in January, 2002 by Nikhilesh Singh and is headquartered in Pt. Richmond, CA.

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA.

SkinMedica, Inc. is a specialty skin care pharmaceutical company. It develops, acquires, and commercializes products for treatment of dermatologic conditions and improvement of skin appearance. It markets and sells to physicians, with a focus on aesthetics, both prescriptions and non-prescription skin care products. SkinMedica was founded in May 1999. Its company headquarters are located in Carlsbad, California. Company already EXT. Filed in HOL tracker.